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Abstract
Objectives: 1. To determine the prevalence of Metabolic Syndrome in adults aged 18 years and above in
Chandigarh, India. 2. To determine the socio-demographic factors associated with MS. 3. To determine the
agreement between IDF (International Diabetes federation definition) and ATP-III (National Cholesterol Education
Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults criteria).
Methods: In a community based cross-sectional study, total 605 subjects aged 18 yrs and above were studied
using multistage random sampling.
Results: Prevalence of Metabolic Syndrome was estimated by using IDF and ATP-III criteria. By IDF, Metabolic
Syndrome was found in 287 (47.4%) subjects and it was more prevalent among females 171 (59.6%) as compared
to males 116 (40.4%). By applying ATP-III overall prevalence was less i.e. 233 (38.5%) but again its prevalence was
more among females 141 (44.8%) than males 116 (39.5%). Higher socioeconomic status, sedentary occupation and
high body mass index were significantly associated with Metabolic Syndrome.
Conclusions: Metabolic Syndrome is a major health problem in the region and proper emphasis should be given
on its prevention and control.
Introduction
MS is a clustering of abnormalities that confers an
increased risk of developing not only cardiovascular dis-
ease (CVD) but also type 2 diabetes mellitus [1]. It has
reached to epidemic proportions worldwide [2]. About
20-30% of adult population worldwide is suffering from
this syndrome [3]. Millions of people in developing
countries are facing a double health burden that repre-
sents an unsettling modern-day paradox i.e. the impact
of poverty-related diseases (associated with infections
and nutrition) is being exacerbated by the increasing
load of chronic non communicable diseases [4].
MS was firstly defined by World Health Organization
(WHO) in 1998 [5], after that many international agen-
cies and organizations purposed various definitions to
screen it. Out of these the most widely used definitions
are by the National Cholesterol Education Program
Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults (ATP-III) proposed
in 2001 [6] and the International Diabetes Federation
(IDF) proposed in 2005 [7]. But all the groups agreed
on the core components of MS that consist of obesity,
insulin resistance, dyslipidemia and hypertension, how-
ever the specific factors and their cutoff values used in
the various definitions were different to identify MS.
According to a recent systematic review of studies
published between 1998 and 2005, has shown the strong
association between the MS and the risk of CVD [8].
MS also increases incidence of coronary heart diseases
and diabetes [9]. Apart from its association with cardio-
vascular disorder and diabetes mellitus, it is a common
soil for numerous other clinical disorders too and so it
has became a matter of great debate.
The prevalence of MS is rapidly increasing in develop-
ing countries due to changing lifestyle. Chandigarh is a
highly urbanized city (90% of population resides in
urban areas) and there seems to be no literature avail-
able regarding MS in Chandigarh except a small school
based study in adolescents [10]. The present community
based study was conducted to screen individuals from
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with its associated factors.
Objectives
1. To determine the prevalence of Metabolic Syndrome
in adults aged 18 years and above in Chandigarh, India.
2. To determine socio-demographic and some other fac-
tors associated with MS. 3. To determine the agreement
between IDF and ATP-III.
Study design
A community based cross-sectional study was con-
ducted in urban and rural and slum populations of
Union Territory, Chandigarh, located in northern India.
Methods
Stratified multistage random sampling was used for
selection of study subjects. The whole population was
divided in to rural and urban strata. At the first stage,
sample of 2 rural and 6 urban wards were selected at
random as primary stage units. Within each primary
stage unit, a sample of one sector in urban area and one
village from rural area were selected at random as sec-
ondary stage units. Within selected second stage units a
sample of households were surveyed as third stage units.
Within selected households, individuals satisfying inclu-
sion criteria were selected to achieve the pre-determined
optimum sample size.
In India the prevalence of MS as available in different
studies, ranges from 20%-40%. On the basis of pilot study
conducted prevalence of 40% was found, by keeping 95%
confidence coefficient and allowing 10% permissible
error the optimum sample size was found to be 576.
Total 606 subjects agreed for biochemical investigations
and one blood sample was hemolysed during transporta-
tion hence 605 respondents were screened for MS.
Individuals aged 18 yrs and above, irrespective of dis-
ease status (diabetics, hypertensives and dyslipidemic
patients were not excluded) were screened for MS, only
pregnant females were excluded from screening. For the
sake of feasibility in terms of time, cost and other con-
siderations, IDF and ATP-III criteria were used for
screening of MS [6,7]. Key points regarding these two
criteria are given in table 1 and table 2.
Participants were interviewed and examined clinically
to get required information. Semi structured schedule
was used to gather information regarding background
characteristics and lifestyle related information. Socio-
economic status was classified using Modified Kuppus-
wamy Socio-economic status scale [11]. Physical activity
was assessed on the basis of occupation and accordingly
it was classified in to sedentary, moderate and heavy
type [12]. Anthropometric measurements which include
waist circumference, weight, and height were done using
standard methods. Body Mass Index (BMI) was classi-
fied according to WHO classification. Blood pressure
measurements were done as per JNC VII guidelines
[13]. Required biochemical parameters: triglycerides
(TG), high density lipids (HDL) and fasting blood sugar
(FBS) levels were estimated in participants who
remained fasting for 12 hours prior to sample collection.
The blood sample was collected using standard blood
sample collection procedure. After labeling blood sam-
p l ev i a l s ,t h e yw e r et r a n s p o r t e dt ob i o c h e m i s t r yl a b o r a -
tory of Government Medical College and Hospital
Chandigarh for further processing.
Statistical tests like Chi square test, Normal tests of
proportions, Student’s t-test, and Analysis of variance
(ANOVA) were applied. Kappa coefficient was used for
studying agreement between IDF and ATP-III criteria
[14]. SPSS-12 software was used for data analysis.
Ethical guidelines of Helsinki (1996) were followed.
Informed consent was taken from all the participants
and any risks involved during investigation were cared
of medically to the possible extent. Information regard-
ing MS was also provided to the participants prior to
survey. Participants were imparted knowledge regarding
prevention of MS after conducting the interview.
Results
Out of 605 participants, 290 (47.9% were males) and 315
(52.1% were females). During sampling, proportional
allocation was given to urban, rural and slum popula-
tions, as 481 (79.5%), 63 (10.4%), and 61 (10.1%) partici-
pants were from respective populations. Participants
from all of the socioeconomic classes and religions were
included in this study. Table 3 and Table 4 show the
prevalence of MS and its association with various socio-
demographic factors by IDF and ATP-III criteria respec-
tively. According to IDF, 287 (47.4%) respondents were
having MS and it was more in females 171 (54.3%) as
compared to males 116 (40%). Prevalence estimates
were less using ATP-III, as 233 (38.5%) individuals had
Table 1 ATP-III definition of Metabolic Syndrome
Three or more of the following five risk factors:
Risk factor Defining level
Central obesity Waist circumference
￿ Men > 102 cm (> 40 in)
￿ Women > 88 cm (> 35 in)
Triglycerides ≥ 150 mg/dL (1.7 mmol/L)
HDL cholesterol
￿ Men < 40 mg/dL (1.03 mmol/L)
￿ Women < 50 mg/dL (1.29 mmol/L)
Blood pressure ≥ 130/≥ 85 mm Hg
Fasting glucose ≥ 110 mg/dL (6.1 mmol/L)
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der were seen, as 141 (44.8%) females compared to 116
(31.7%) males were having MS.
Mean age of study population was 44.99 ± 14.74 yrs,
but it was more in respondents with MS with both cri-
teria. It was 49.46 ± 13.24 yrs in respondents with MS
according to IDF (p < .001) and 50.55 ± 13.24 yrs in
respondents with MS according to ATP-III (p < .001).
Increasing trends of prevalence with age were seen with
both IDF and ATP-III.
MS was more prevalent in urban area, by using both
criteria. About 249 (51.8%) urban residents were having
MS (IDF) as compared to 26 (41.3%) rural residents and
12 (19.7%) slum dwellers (p < .001). Similarly, preva-
lence of MS (ATP-III) was also more in urban residents
198 (41.2%) as compared to 22 (34.9%) rural residents
and 13 (21.3%) slum dwellers (p = .009).
MS was more prevalent among respondents belonging
to upper socioeconomic as compared to lower classes
and there association was statistically significant (p =
.006 and p = .021 respectively for IDF and ATP-III). MS
was more prevalent among respondents belonging to
Sikh religion. Prevalence was 58.2% in Sikhs followed by
Hindus (42.2%), Christians (40%) and Muslims (35%) by
IDF and it was statistically significant (p = .002). By
ATP-III prevalence among Sikhs was 45.2%, Hindus
(35.2%), Christians (40%), and Muslims (30%) but this
association was statistically insignificant (p = .100).
It has been found that type of occupation, is significantly
associated with MS (IDF) as 259 (51.4%) respondents
involved in sedentary habitat were having MS as compared
to 28 (30.1%) respondents of moderate type of work and
none of the respondents involved in heavy work were hav-
ing MS (p < .001). Parallel results were found by using
ATP-III too. As 211 (41.9%) participants involved in
sedentary habitat MS as compared 22 (23.7%) involved in
moderate type of physical activity and none of the respon-
dents involved in heavy activity had MS (p < .001).
Highly significant association of BMI with MS has
been found by using both IDF and ATP-III criteria.
None of the respondents from underweight group and
only 51 (19.2%) individuals with normal BMI had MS
(IDF). Prevalence of MS (IDF) increased from 67.5% in
respondents from preo-obese class to 100% in
respondents of obese class III. This association was
highly significant (p < .001). Same trends were found by
using ATP-III also (p < .001). Mean BMI of study popu-
lation was low i.e. 25 ± 4.13 yrs as compared to the
respondents with MS (IDF) 27.89 ± 3.02 years and
respondents with MS (ATP-III) 27.95 ± 4.15 years.
The agreement between ATP-III and IDF criteria was
f o u n db yu s i n gk a p p ac o e f f icient of agreement and it
was 0.636 and it is highly significant (P < .001).
Discussion
Prevalence world wide IDF vs. NCEP ATP-III
In the present study prevalence of MS was estimated by
using both IDF and ATP-III criteria and overall preva-
lence rates were found as 47.5% and 38.5% respectively.
Higher prevalence (by using IDF) can be explained by
the lower cut-off points adopted by this new definition.
In IDF, central obesity is the major criterion, its cut off
is ethnic specific and is lower for Indians than used by
original ATP-III. Another difference among two defini-
tions is lower cutoff for FBS by IDF, which is > 100 as
compared to > 110 in ATP-III.
The higher prevalence by new IDF definitions is com-
parable with other reports. Hu et al conducted a study
i nF i n l a n da n df o u n dt h a tp r e v a l e n c ew a s3 9 . 1 %b y
ATP-III and 45.3% by IDF definition [15]. Similarly
study done by Can et al concluded that prevalence was
42% by IDF and 38% by ATP-III in Turkish adults [16].
Similar results were also found by Harzallah et al [17] in
Arab population (45.5% by IDF vs. 24.3% by ATP-III).
Prevalence in India
In India very few studies had been done to find preva-
lence of MS and most of the studies which are available
in literature had used ATP-III. But Deepa et al [18]
compared the prevalence of MS in south Indian popula-
tion by various definitions and found that by IDF 25.8%
individuals > 20 yrs were having MS as compared to
18.3% by ATP-III. Another study from Bangalore by
Kanjlal et al [19] concluded that prevalence of MS (by
ATP-III) was 40.3% as compared to 34.9% by IDF defi-
nition. But no comparable study from north India is
present in literature which has compared these two defi-
nitions. Gupta et al estimated the prevalence in Bhatia
Table 2 IDF definition of Metabolic Syndrome
Central obesity (defined as waist circumference ≥ 90cm for Asian men ≥ 80cm for Asian women, with ethnicity specific values for other groups) plus
any two of the following four factors:
1. Raised TG level: ≥ 150 mg/dL (1.7 mmol/L), or specific treatment for this lipid abnormality
2. Reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males and < 50 mg/dL (1.29 mmol/L) in females, or specific treatment for this lipid
abnormality
3. Raised blood pressure: systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg or Treatment of previously diagnosed hypertension
4. Raised fasting plasma glucose (FPG) ≥ 100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes
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Page 3 of 8Table 3 Metabolic Syndrome (IDF) with various socio-demographic factors
Socio demographic factor Metabolic Syndrome
(IDF)
Total
No. (% age)
P value
Yes
No. (% age)
No
No.(% age)
Gender
Male 116 (40.4)
(40.0)*
174 (54.7)
(60.0)*
290 (47.9)
(100.0)*
p < .001
Female 171 (59.6)
(54.3)
144 (45.3)
(45.7)
315 (52.1)
(100.0)
Age
18-25 yrs 5 (1.7)
(9.4)
48 (15.1)
(90.6)
53 (8.8)
(100.0)
p < .001
26-35 yrs 35 (12.2)
(30.7)
79 (24.8)
(60.3)
114 (18.8)
(100.0)
36-49 yrs 114 (39.7)
(50.7)
111 (34.9)
(49.3)
225 (37.2)
(100.0)
50-59 yrs 56 (19.5)
(61.5)
35 (11.0)
(38.5)
91 (15.0)
(100.0)
60-65 yrs 42 (14.6)
(63.6)
24 (7.5)
(36.4)
66 (10.9)
(100.0)
>65 yrs 35 (12.2)
(62.5)
21 (6.6)
(37.5)
56 (9.3)
(100.0)
Mean ± SD 49.46 ± 13.24 44.96 ± 14.88 44.99 ± 14.74
Background
Urban 249 (86.8)
(51.8)
232 (73.0)
(48.2)
481 (79.5)
(100.0)
p < .001
Rural 26 (9.1)
(41.3)
37 (11.6)
(58.7)
63 (10.4)
(100.0)
Slum 12 (4.2)
(19.7)
49 (15.4)
(80.3)
61 (10.1)
(100.0)
Socioeconomic status
Upper-upper 9 (3.1)
(64.3)
5 (1.6)
(35.7)
14 (8.8)
(100.0)
p = .006
Upper-middle 190 (66.2)
(51.6)
178 (56.0)
(48.4)
368 (60.8)
(100.0)
Upper-lower 55 (19.2)
(44.4)
69 (21.7)
(55.6)
124 (20.5)
(100.0)
Lower 33 (11.5)
(33.3)
66 (17.7)
(66.7)
99 (16.4)
(100.0)
Religion
Hindu 157 (54.7)
(42.2)
215 (67.6)
(57.8)
372 (61.5)
(100.0)
p = .002
Sikh 121 (42.2)
(58.2)
87 (27.4)
(41.8)
208 (34.4)
(100.0)
Muslim 7 (2.4)
(35.0)
13 (4.1)
(65.0)
20 (3.3)
(100.0)
Christian 2 (0.7)
(40.0)
3 (0.9)
(60.0)
5 (0.8)
(100.0)
Physical activity
Sedentary 259 (90.2)
(51.4)
245 (77.0)
(48.6)
504 (83.3)
(100.0)
p < .001
Moderate 28 (9.8)
(30.1)
65 (20.4)
(69.9)
93 (15.4)
(100.0)
Heavy 0 (0.0)
(0.0)
8 (2.5)
(100.0)
8 (1.3)
(100.0)
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was 36.2% in males and 47.8% in females [20].
Reddy et al [21] conducted a multicentric study in
subjects 20-69 yrs of age belonging to industrial employ-
ees or their family members. They used ATP-III and
higher prevalence was found in Bangalore i.e. 38.8%
comparable to current study (38.5%), Trivandrum 37.9%,
Hyderabad 33.0%, Lucknow 29.0% but lower prevalence
was found in Nagpur and Dibrugarh High prevalence of
MS in present study could be attributed to modern life
style adopted by residents of a highly urbanized popula-
tion of Chandigarh, an Union Territory of India,
MS with age and gender
In this study prevalence of MS (IDF) was highest i.e.
63.6% in age group of 60-65 years followed by age
group of > 65 years i.e. 62.5% and lowest among age
group of 18-25 years i.e. 9.4%. Prevalence was more
among females than males by both IDF (M = 40.0%, F =
54.3%) and ATP-III (M = 31.7%, F = 44.8%). An overall
increasing trend was reported in prevalence rates with
increasing age by both definitions. This finding was in
concordance with the study conducted by Kanjlal et al
in Bangalore [19], who reported maximum prevalence in
age group of 50-59 years and Reddy et al [21] who
reported maximum prevalence among age group > 60
years in multi-centric industrial population of India.
Similar trends were also reported by a study done by
Taylor et al [22] in African-American population, who
studied the prevalence in age group 21-94 years and
maximum prevalence was seen in 65-74 year age group
and lowest was seen among 21-34 year age group. Pre-
valence of MS was 44.8% in females and 33.4% among
males. Another study done by Hildrum et al [23] in
Norwegian population also found the similar trends in
prevalence according to age and gender.
Urban Rural Prevalence comparison
Prevalence of MS was highest among urban residents
(51.8%, 41.2%) followed by rural population (41.3%, 34.9%)
and prevalence in slum residents was lowest (19.7%,
21.3%) by both IDF and ATP-III definitions. But interest-
ingly prevalence of MS by ATP-III was more among slum
residents as compared to IDF definition. It could be due to
less prevalence of central obesity among slum residents
because of less sedentary lifestyle and central obesity is a
major criterion in IDF as compared to ATP-III. Mahadik
et al [24] also compared the prevalence among urban and
rural populations of India and prevalence was more
among urban as compared to rural residents (35.2% vs.
20.6%). Ramirez-Vargas et al [25] also found that preva-
lence of MS was more in urban as compared to rural
populations (45.4% vs. 27.6%) in Oaxaca, Mexico. Another
study by Sarkar et al [26] also revealed the effect of urbani-
zation by comparing the prevalence of MS among two
tribes of sub-Himalayan region of India.
MS with Religion
Present study also showed the significant correlation
between MS and religion. Sikh community had highest
prevalence of MS (58.2%, 45.2%) followed Hindus (42.2%,
35.2%) by both IDF and ATP-III definitions but maximum
number of respondents were from Hindu religion (61.5%).
This difference occurred probably because of difference in
the dietary habits of different communities. No compar-
able study could be found in the literature.
Table 3: Metabolic Syndrome (IDF) with various socio-demographic factors (Continued)
BMI
Underweight 0 (0.0)
(0.0)
18 (5.7)
(100.0)
18 (3.0)
(100.0)
p < .001
Normal 51 (17.8)
(19.2)
215 (67.6)
(80.8)
266 (44.0)
(100.0)
Pre-obese 162 (56.4)
(67.5)
78 (24.5)
(32.5)
240 (39.7)
(100.0)
Obese Class I 63 (22.0)
(91.3)
6 (1.9)
(8.7)
69 (11.4)
(100.0)
Obese Class II 9 (3.1)
(90.0)
1 (0.3)
(10.0)
10 (1.7)
(100.0)
Obese Class III 2 (0.7)
(100.0)
0 (0.0)
(0.0)
2 (0.3)
(100.0)
Mean ± SD 27.89 ± 23.16 ± 3.17 25.40 ± 4.13
Total 287 (100.0)
(47.4)
318 (100.0)
(52.6)
605 (100.0)
(100.0)
*Percentage in second row (in bold letters) represents percentage within that group in Table 3 and Table 4
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Socio demographic factor Metabolic Syndrome
(ATP-III)
Total
No. (% age)
p value
Yes
No. (% age)
No
No. (% age)
Gender
Male 116 (39.5)
(31.7)
198 (53.2)
(68.3)
290 (47.9)
(100.0)
p < .001
Female 141 (44.8)
(44.8)
174 (46.8)
(55.2)
315 (52.1)
(100.0)
Age
18-25 yrs 4 (1.7)
(7.5)
49 (13.2)
(92.5)
53 (8.8)
(100.0)
p < .001
26-35 yrs 25 (10.7)
(21.9)
89 (23.9)
(78.1)
114 (18.8)
(100.0)
36-49 yrs 87 (37.3)
(38.7)
138 (37.1)
(61.3)
225 (37.2)
(100.0)
50-59 yrs 48 (20.6)
(52.7)
43 (11.6)
(47.3)
91 (15.0)
(100.0)
60-65 yrs 38 (16.3)
(57.6)
28 (7.5)
(42.4)
66 (10.9)
(100.0)
>65 yrs 31 (13.3)
(55.4)
25 (6.7)
(44.6)
56 (9.3)
(100.0)
Mean ± SD 50.55 ± 13.24 41.51 ± 14.58 44.99 ± 14.74
Background
Urban 198 (85.0)
(41.2)
283 (76.1)
(58.8)
481 (79.5)
(100.0)
p = .009
Rural 22 (9.4)
(34.9)
41 (11.0)
(65.1)
63 (10.4)
(100.0)
Slum 13 (5.6)
(21.3)
48(12.9)
(78.7)
61 (10.1)
(100.0)
Socioeconomic status
Upper-upper 9 (3.9)
(64.3)
5 (1.3)
(35.7)
14 (8.8)
(100.0)
p = .021
Upper-middle 153 (65.7)
(41.6)
215 (57.8)
(58.4)
368 (60.8)
(100.0)
Upper-lower 38 (16.3)
(30.6)
86 (23.1)
(55.6)
124 (20.5)
(100.0)
Lower 33 (14.2)
(33.3)
66 (17.7)
(66.7)
99 (16.4)
(100.0)
Religion
Hindu 131 (56.2)
(35.2)
241 (64.8)
(64.8)
372 (61.5)
(100.0)
p = .100
Sikh 94 (40.3)
(45.2)
114 (30.6)
(54.8)
208 (34.4)
(100.0)
Muslim 6(2.6)
(30.0)
14(3.8)
(70.0)
20 (3.3)
(100.0)
Christian 2 (0.9)
(40.0)
3 (0.8)
(60.0)
5 (0.8)
(100.0)
Physical activity
Sedentary 211 (90.6)
(41.9)
293 (78.8)
(58.1)
504 (83.3)
(100.0)
P < .001
Moderate 22 (9.4)
(23.7)
71 (19.1)
(76.3)
93 (15.4)
(100.0)
Heavy 0 (0.0)
(0.0)
8 (2.2)
(100.0)
8 (1.3)
(100.0)
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This study had shown the significant association of MS
with socioeconomic status of respondents. MS was
found to be more prevalent among subjects belonging
to upper socioeconomic status as compared to lower
classes. This finding was in concordance to the study
done by Mohan et al [27] in South India where in sig-
nificant difference in prevalence of MS was found
according to socioeconomic status. MS was higher in
middle compared to low income groups But in studies
from developed countries and have shown the contrast
results as Dallongeville et al [28] found that household
income and education had an inverse relation with MS
in France.
Agreement of IDF and NCEP ATP-III
Significant agreement between ATP-III and IDF criteria
for detecting MS indicates that we can use either of
these two criteria for detecting MS. Optimum decisions
may depend upon epidemiological situations. Choi et al
[29], reported the agreement between ATP-III and the
IDF as ( = 0.54) in the Korean population.
Conclusions
This study concludes that Metabolic Syndrome is highly
prevalent in the urbanized community. Its contributory
complications demand, screening of individuals in the
community at the earliest, so that lifestyle modifications
strategies may be adopted at an early age. Significant
agreement between ATP-III and IDF criteria suggests
possible use of IDF which restricts the blood investiga-
tions only if of central obesity is present as it is a major
criterion. IDF may be a more feasible, practical and cost
effective approach in the community set-up. This preli-
minary study in the region with IDF definition sets the
background for future prospective studies, regarding
causation, prevention and management of this
syndrome.
Limitations
In this study only demographic factors are presented,
risk factor analysis should have been done by using pro-
spective study.
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Table 4: Metabolic Syndrome (ATP-III) with various socio-demographic factors (Continued)
BMI
Underweight 1 (0.4)
(5.6)
17 (4.6)
(94.4)
18 (3.0)
(100.0)
P < .001
Normal 51 (21.9)
(19.2)
215 (57.8%)
(80.8)
266 (44.0)
(100.0)
Pre-obese 110 (47.2)
(45.8)
130 (34.9)
(54.2)
240 (39.7)
(100.0)
Obese Class I 60 (25.8)
(87.0)
9 (2.4)
(13.0)
69 (11.4)
(100.0)
Obese Class II 9 (3.9)
(90.0)
1 (0.3)
(10.0)
10 (1.7)
(100.0)
Obese Class III 2 (0.9)
(100.0)
0 (0.0)
(0.0)
2 (0.3)
(100.0)
Mean ± SD 27.95 ± 4.15 23.81 ± 3.23 25.40 ± 4.13
Total 233 (100.0)
(38.5)
372 (100.0)
(61.5)
605 (100.0)
(100.0
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